[Chagas' disease: persistent production of a T lymphocyte glycoprotein in patients treated with anti-Trypanosoma cruzi agents].
D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use; D014355:Chagas Disease / Q000097:blood*; D006023:Glycoproteins / Q000096:biosynthesis*; D006651:Histocytochemistry; D006801:Humans; D009547:Nifurtimox / Q000627:therapeutic use; D009581:Nitrofurans / Q000627:therapeutic use; D023303:Oxazolidinones; D010503:Periodic Acid-Schiff Reaction; D013601:T-Lymphocytes / Q000378:metabolism*; D014344:Trypanocidal Agents / Q000494:pharmacology; D014349:Trypanosoma cruzi / Q000378:metabolism*
D000892:Anti-Infective Agents, Urinary; D006023:Glycoproteins; D009581:Nitrofurans; D023303:Oxazolidinones; D014344:Trypanocidal Agents; C007795:furaltadon; D009547:Nifurtimox
Enfermedad de Chagas: persistente producción de una glicoproteina de linfocitos T en pacientes tratados con agentes anti Trypanosoma cruzi.